Background. Individuals with a first-degree family history of colorectal cancer (CRC) are at increased risk of CRC. Study objectives were: (1) to estimate the proportion of first-degree relatives (FDR) of CRC patients being screened for CRC and (2) to identify predictors of screened behavior. Methods. A questionnaire was mailed to 640 stage I-III CRC patients from a population-based registry to identify FDR. A survey was sent to 747 FDR, aged 40 or older, to assess CRC screening, knowledge, demographics, access, benefits, and barriers of CRC screening. Factor analysis was used to detect underlying constructs. Predictors of screening were explored by multivariate analysis (MVA).
MVA determined age [50 years as the most important predictor of screening. Conclusion. In this survey, 70% of FDR of CRC patients had undergone screening; age was the most important predictor. Understanding underlying constructs influencing screening behavior may improve uptake of CRC screening in this population.
Colorectal carcinoma (CRC) is the third most common malignancy and the second leading cause of cancer-related death in Canada. 1 CRC is an ideal tumor for populationbased screening because of its high incidence, long lag time between adenomatous polyp and carcinoma, and increased potential for curative treatment when detected at an earlier stage. [1] [2] [3] The Canadian Task Force on Preventive Care has recommended CRC screening in all average-risk individuals, although a standardized screening program has not been adopted in Canada. 4 At present, widespread screening for CRC of all average risk individuals is not occurring in Canada. 5, 6 An alternate strategy is to focus on individuals with a first-degree family history of CRC with an increased risk of developing CRC for an introductory standardized screening program. 7, 8 While the Canadian Task Force on Preventive Health Care does not currently recommend more intensive screening in this subgroup compared with all average-risk individuals, other groups including the U.S. Preventive Services Task Force, the American Society of Colon and Rectal Surgeons, and the American Cancer Society do recommend more intensive CRC screening in this population starting at age 40 years or 10 years prior to the age at diagnosis of their first-degree relative (FDR). [9] [10] [11] Screening with colonoscopy is commonly, although not uniformly, recommended by these groups. Similarly, a physician survey of a large Canadian center found 96% recommended CRC screening in those with a positive first-degree family history of CRC, generally with colonoscopy (84% of respondents). 12 Currently, there is a paucity of data about actual screening prevalence in this population subgroup. There is little data from the individual's viewpoint as to their acceptance, knowledge, perceived needs, beliefs, or concerns regarding CRC screening. The main objectives of the current study were to estimate the proportion of FDRs of CRC patients being screened for CRC in an urban Canadian center and to identify predictors of screening behavior.
METHODS

Population
All living colorectal cancer patients (stage I-III) in the Calgary Health Region diagnosed from 2001 to 2003 were identified via the Alberta Cancer Registry. Primary CRC patients were approached with an information letter about the survey and a data sheet to obtain contact information of their FDRs. Patients were asked whether they had FDRs age 40 or older, the number of these eligible relatives, and whether they would be interested in completing a study questionnaire. The age of 40 years was chosen to limit respondents primarily to those with a moderate risk of developing CRC such as those with one or two family members with CRC rather than very high risk families such as familial adenomatous polyposis or hereditary nonpolyposis colorectal cancer (HNPCC). The time period of 2001-2003 was chosen to provide 4-6 years between the diagnosis of CRC and the survey implementation. The rationale was to ensure ample time for FDRs to be aware of the diagnosis of CRC in their family member and to become aware of and access CRC screening if desired. An information letter and mail-in study questionnaire was sent to all identified FDRs of CRC patients.
Questionnaire Design and Implementation
The study questionnaire was designed using modifications of a prior Alberta general population survey, scales developed by Rawl et al., and data elements measuring CRC adherence from Tiro et al. [13] [14] [15] More specifically, demographic questions related to ethnic origin, language, level of education, marital status, employment status, age, and income were modified from a prior general population survey, and questions regarding self-related health status, access to a family physician, screening knowledge, sources of screening knowledge, and self-reported screening habits were added. The major outcome element of the survey was self-reported CRC screening prevalence. Scales developed by Rawl et al. assessing attitudes and potential benefits and barriers to CRC screening were modified for the current survey.
14 Instead of specific questions regarding benefits and barriers of each screening modality (i.e., fecal occult blood testing, sigmoidoscopy, and colonoscopy), these questions were modified to discuss CRC screening overall. Standardized descriptions of CRC screening tests were included in the survey.
14 Data items that did not overlap with the scales of Rawl et al. were added from Tiro et al. to address further potential predictors of CRC screening adherence. 15 The survey was improved to provide face validity, ease of comprehension, and ease of completion.
The survey mail out and return occurred from March to June 2007 inclusive. To ensure a maximal response to the initial letter sent to CRC patients as well as the questionnaire sent to FDRs, many elements of Dillman's tailored design approach for mail-in surveys were used. 16 A cover letter was personalized and delivered by the Alberta Cancer Registry. Confidentiality was assured, datasheets and questionnaires had clear instructions with an attractive layout and a stamped addressed return envelope was included. Appreciation for participating was given by the investigators including a token financial incentive (draw for $100.00). 17, 18 Reminder letters to nonrespondents were sent out 3 weeks following the initial information and datasheet mail-out. 16 The entire package was sent to continued nonresponders 3 weeks later. Letters to FDRs noted permission for contact had come from their family member.
Analysis
Returned questionnaires were entered into a Microsoft Access database (Microsoft Inc., Redmond WA), and data transfer to SPSS occurred for further analysis (SPSS Inc., Chicago IL). To ensure a sufficient sample, 640 patients were identified prior to the initiation of the study. Based on overall response rates to mail-in medical surveys, it was estimated that 50-60% (320-384) of CRC patients would return contact information of first-degree relatives. 19 It was further estimated that each patient would have two living, eligible first-degree relatives ensuring a potential pool of first-degree relatives of at least 600. A priori sample size calculation required approximately 200 respondents to obtain an estimate of whether they were a screener or nonscreener with a precision of 10% or better.
Analyses included the proportion of those screened, the proportion of those interested in screening as well as descriptive analyses (proportions) of individual demographics, health knowledge and characteristics, screening knowledge and habits, as well as descriptive analyses of potential benefits and barriers of screening. Appropriateness of screening interval was defined as within 1 year of the survey for fecal occult blood testing, within 5 years for barium enema or sigmoidoscopy, or within 10 years for colonoscopy.
Univariate analysis was performed to assess for potential predictors of screening behavior (chi-square tests) including demographic data (age, education level), personal history of cancer, whether one has a regular family doctor, and whether one has a regular annual examination. Variables were determined to be significant if P values were B.05. An exploratory factor analysis was performed using a principle components analysis with varimax rotation to assess whether the survey instrument separated Likert scale questions and responses (19 benefits and barriers questions) into the constructs for CRC screening adherence as described by Vernon et al. 20 This type of analysis is used to reduce information from several survey items to a smaller number of important factors. Cronbach alpha reliability measures were determined for each scale item separately and overall. A multivariate backwards logistic regression model with screening behavior as the dependent variable was developed using important demographic and health-related variables-education level, marital status, employment, age C50 years, self-reported health rating, having a family physician, having an annual examination, personal history of cancer, knowledge of the term ''screening,'' and constructs determined from the factor analysis. The backwards selection continued through nine iterations until all remaining variables had a significance level \0.06.
The study was approved by the Conjoint Health Research Ethics Board, University of Calgary. The current project was supported by an Alberta Cancer Board Heritage Research Grant through the Clinical Research Unit at the Tom Baker Cancer Centre, Calgary, Alberta, Canada.
RESULTS
The Alberta Cancer Registry identified 640 living CRC patients (stage I-III) as having been diagnosed in the Calgary Health Region from 2001 to 2003. Of these, 343 of 640 (54%) returned information regarding 747 FDRs (mean 2.2 relatives per patient). The study questionnaire was sent to all identified FDRs and returned by 383 of 747 (51%). There were 27 who returned the surveys completely blank, indicating they did not wish to participate. In total, 356 completed study questionnaires were returned by FDRs of CRC patients, exceeding the a priori sample size of 200 required ensuring an estimate of the prevalence of CRC screening with 95% confidence of a precision estimate within 5%.
General demographics of respondents are presented in Table 1 . The majority of respondents were born in Canada (86%), spoke English at home (94%), and 93% had at least completed a high school education. Approximately 70% Approximately 90% (319 of 356) of respondents recorded their health in the categories good, very good, or excellent (Table 2 ). Access to health care was excellent: the majority of respondents had a family doctor (93.5%) and had routine examinations at least once a year (74%). Overall, 55 respondents (15%) had a prior diagnosis of cancer themselves including 9 (2.5%) already diagnosed with CRC.
Approximately 92% of respondents had heard of the term screening, although many respondents incorrectly felt the term meant checking or testing for symptoms of a disease (38.8%); see Table 2 . Approximately three-quarters (76.1%) felt the term ''early detection'' correctly meant ''catching disease at early stage when treatable and not too serious.'' Most respondents had heard of common, currently available screening tests; although knowledge was test specific. More than 90% had heard of colonoscopy as a screening test with most respondents (80%) noting their family doctor as a source of screening knowledge; family and friends were also a common source of knowledge (75.8%).
The major outcome of the study is self-reported colorectal cancer screening prevalence by FDR aged 40 years or older of living CRC patients (stage I-III) diagnosed in the Calgary Health Region 2001-2003. The percentage of those who reported having ever had any CRC screening test was 70%. Of the entire sample of 356 respondents, approximately 34% and 59% reported ever having fecal occult blood testing or colonoscopy, respectively (Table 3) . Approximately 17% had screening within the last year, 46% had screening within 1-5 years, 5% had screening within 6-10 years, 2.8% had screening more than 10 years ago, and 30% had never undergone screening. There appeared to be an appropriate screening interval (within 1 year for fecal occult blood testing, within 5 years for barium enema or sigmoidoscopy, or within 10 years for colonoscopy) in 60% of the entire sample. The percentage of respondents who stated they were interested in pursuing a screening test for bowel cancer was 85%.
Survey answers to the benefits and barriers to CRC screening section are presented in Table 4 . There were 2-6 respondents (0.6%-1.7%) who failed to respond to 5) , and the overall Cronbach alpha reliability measure was 0.813. Since similar questions were modified from Rawl et al. as well as Tiro et al., it follows that similar concepts or constructs are being tested in the current study survey.
14, 15 Tiro et al. describe five major constructs of CRC screening adherence including ''salience and coherence,'' ''cancer worries,'' ''social influence,'' ''susceptibility,'' and ''response efficacy,'' correlating with factors 1-5 in this analysis. 15, 20 Older age (P \ .0001), having a family physician (P = .05), having a regular annual checkup (P = .002), and a personal history of cancer (P = .007) was associated with ever having been screened with univariate analysis. Education level was not significant. Further analysis combined demographic factors and health questions with the five constructs from the benefits and barriers survey. The final model including age, employment status, and four constructs (cancer worries, social influence, susceptibility, and response efficacy) is presented in Table 5 . Age is the strongest predictor, with age greater than 50 years positively associated with having undergone colorectal cancer screening (odds ratio [OR] 3.64, 95% confidence interval [CI] 2.001-6.621, P \ .0001).
Three constructs from the factor analysis-social influence, cancer worries, and response efficacy-were associated with CRC screening, although their effect was The model is correct in predicting 'no screening' in 51.5% of respondents, correct in predicting 'screening' in 90.2% of respondents, and the overall accuracy rate is 79.1%.
DISCUSSION
The self-reported prevalence of CRC screening in FDRs aged 40 years or older of living stage I-III CRC patients was 70%. Of the current sample, 70% had ever undergone CRC screening, although 60% were up to date with screening recommendations. Of those screened, the majority (84%) had been screened via colonoscopy (i.e., 59% of the entire sample). The study response rate exceeded the a priori calculated minimum sample size ensuring a good estimate of CRC screening prevalence. Also, the sample appears similar to a prior general population survey by McGregor et al. for major demographic variables; allowing for differences in age considering the current survey was of first-degree relatives aged 40 years or older and the general population survey was of Albertans aged 50-74 years. 13 The results of this survey should be generalizable to other areas in Canada. Generalization to other geographic areas should be made carefully. Colorectal cancer screening in the United States and other countries may be different related to the influence of medical insurance status as well as cultural differences. 21, 22 Although direct comparison of different screening prevalence is difficult because of different time frames of ascertainment and different inclusion criteria, CRC screening prevalence in this population appears much higher than in the general population. Prior general population surveys by the National Cancer Institute of Canada (NCIC) as well as Alberta and Ontario surveys estimate between 4% and 23% of eligible Canadians have undergone CRC screening. 6, 13, 23 CRC screening prevalence in the study population also appears higher than general population CRC screening behavior in the United States, where many studies report a larger proportion have undergone screening (range 43%-54%). [24] [25] [26] Few studies have assessed CRC screening prevalence among FDRs of CRC patients specifically. Of the 2004 general population survey by McGregor et al., 134 respondents had C1 FRD with a diagnosis of CRC, and CRC screening prevalence was 42.9% among this group. 13 The general population survey of Ramji et al. notes 228 individuals with a first-degree family history of CRC, which was the strongest correlate of having CRC screening (OR = 2.5, 95% CI 1.7-3.8). 23 A survey of FDRs in the Ontario Familial Colon Cancer Registry (OFCCR) reported 64% of respondents had been screened for CRC in the past 6 years; however, the OFCCR oversampled FDR of particularly high-risk families including those with HNPCC.
27,28 U.S. surveys of FDRs of CRC patients have self-reported CRC screening prevalence of 57%-60%. 21, 29 The current survey results report a higher than anticipated proportion of FDRs having undergone screening. Potential explanations include the current survey is the most recent, overestimation of CRC screening behavior due to self-reporting, or a difference in screening prevalence between those responding to versus not responding to the survey (response bias). Individuals tend to overestimate their actual screening prevalence, although most studies find an accuracy of 80%-97%, which is more accurate than physician surveys. 24, [30] [31] [32] Response bias may be more of a concern. Madlensky et al. note a significant difference in screening status among participants and nonparticipants in a survey of the Ontario Familial Colon Cancer Registry (OFCCR) at 61% and 34%, respectively. 28 Unfortunately, the current study cannot compare participants and nonparticipants in this manner since no information was gathered on nonparticipants. Older age is a consistent correlate with CRC screening in the literature. 21, 28 The current survey was limited to those age 40 years or older; the age where most physicians recommend CRC screening for this population. 4, [9] [10] [11] [12] 33, 34 Approximately 51% of respondents aged 40 to 49 years had undergone CRC screening compared with 83.8% of those age 50 years or older (P \ .0001) and remained statistically significant following multivariate analysis with an odds ratio of 3.64 (95% CI 2.001-6.621) in favor of being screened in the older age group. Similarly, Codori et al. found for every 10-year advance in age, the odds of endoscopy screening among first-degree relatives of CRC patients increased by 2.4. 21 Vernon et al. describe several theoretical constructs that may influence CRC screening behavior including: salience and coherence, perceived susceptibility, response efficacy, social influence, and cancer worries; most from the Health Belief Model. 20, 35 Salience and coherence is the perception that performing a health behavior is consistent with other beliefs about how to protect and maintain health. 15, 20 Perceived susceptibility is the subjective personal risk of developing CRC or polyps. 15 Response efficacy is the belief that adopting a certain behavior (i.e., colonoscopic screening) will be effective in reducing one's risk. 15 Social influence is the desire to comply with CRC screening because of influences from physicians or a family member. 15 Finally, cancer worries reflect potential negative consequences of completing a behavior (i.e., screening). 15 After age, the construct of social influence most strongly influenced CRC screening and is the area most likely to be positively effected. After univariate analysis, those with a family physician and those having an annual routine examination predicted higher screening prevalence; similar to surveys of FDRs identified by U.S. cancer registries. 21, 29 Although access to a family physician or annual examination was not significant after multivariate analysis, the underlying construct of social influence did significantly predict screening behavior (odds ratio 1.48, 95% CI 1.281-1.701). It is important to note two of three questions of the construct social influence dealt directly with the role of family or primary care physicians in influencing CRC screening: ''My doctor thinks I should have bowel cancer screening'' and ''I want to do what my doctor thinks I should do about colorectal cancer screening''. Similarly, Madlensky et al. and Manne et al. found physician recommendation was the strongest correlate of CRC screening behavior in surveys of FDRs. 28, 29 Conversely, several authors cite lack of physician recommendation as a barrier to CRC screening. 36, 37 A desire to agree with family about undergoing CRC screening was related to screening behavior in the current survey via the constructs of social influence as discussed previously as well as perceived susceptibility. 15, 20 Many individuals perceive a higher overall risk (perceived susceptibility) of developing CRC if a FDR has been affected. 21, 29, 38, 39 Interestingly, many respondents (49%) in the current survey did not know their risk of developing CRC in a relative sense (i.e., compared with other high-risk individuals).
The construct of cancer worries did correlate with CRC screening behavior, but disagreeing with question items appeared to correlate with screening behavior. As expected, those disagreeing with ''I am worried that bowel cancer screening will show that I have bowel cancer or polyps'' were more likely to have been screened. Fear of positive results and fear of embarrassment and messiness of tests are common barriers found in qualitative analysis using focus groups of FDRs. 36, 40 Specific education regarding actual risks of CRC and the overall process of CRC screening may improve CRC screening uptake. 41 Personal cancer history did correlate with CRC screening on univariate analysis, although was not significant following multivariate analysis. Few studies of FDRs address this factor, although Madlensky et al. found no correlation either. 28 CRC screening promotion may be less important in a group who have already been diagnosed with cancer.
A systematic review of case-control and cohort studies estimates that FDRs of CRC cancer patients have a 2.42 times (95% CI 2.20-2.65) increased risk of developing colon carcinoma. 8 Risk increased further with increasing number of FDRs affected and in relatives of patients diagnosed with CRC when less than 45 years of age. However, current guidelines of CRC screening in individuals with a first-degree family history of CRC are inconsistent. The Canadian Task Force on Preventive Health does not currently recommend more intensive screening in this group compared with the general population. 4 Provincial guidelines vary. 34 The Alberta Cancer Board published guidelines for CRC screening of moderate-risk individuals since the implementation of this survey. 42 An individual with one FDR with CRC diagnosed at age 60 years or older is recommended to have the same screening as average-risk individuals but commencing at age 40 years. Those with a FDR diagnosed less than 60 years or with two or more FDRs diagnosed with CRC, colonoscopy is recommended every 5 years starting at age 40 or 10 years younger than the earliest case in the family. North American guidelines for CRC screening for FDRs are also somewhat variable. [9] [10] [11] 33 A prior survey of physicians in the same geographic area as the current study found colonoscopy is usually recommended in this risk group and usually starting at age 40. 12 Further, most physicians would choose colonoscopy if they themselves were to undergo CRC screening. 5 A clear, evidence-based guideline consistent among all professional groups should be developed for individuals with a first-degree family history of CRC as inconsistent recommendations are a known barrier to CRC screening. 5, 36, 40 Since guidelines alone may not change clinical practice significantly, provincial cancer registries may consider distributing CRC screening guidelines to FDRs directly indicating their increased risk. 13, 43 Ethical issues regarding privacy of information would have to be debated for this to occur; however, this may be an idealistic option considering CRC patients substantially underreport CRC arising in first-and second-degree relatives. 44 The NCIC notes populationbased screening is most effective when administered through an organized screening program that incorporates all elements of the screening process: evidence-based screening, follow-up, recruitment and retention strategies, comprehensive quality assurance, and information systems in support of program operation, monitoring, and evaluation. 6 The incidence and mortality rates of colorectal cancer in Canada are among the highest in the world. 1 FDRs of CRC patients are at an even higher risk of developing CRC, and currently there is no organized national CRC screening program in Canada. 7, 8, 45, 46 The current survey found selfreported CRC screening estimates of 70% in this group, 60% were up to date with screening recommendations, yet 85% were interested in pursuing CRC screening. Important predictors of CRC screening in this population include age greater than 50 years and the construct social influence which includes physician and family influence. Although more individuals appear to be screened in this higher-thanaverage risk group compared with the general population, there is a gap between CRC screening recommendations, screening prevalence, and interest in undergoing CRC screening. An organized CRC screening program is required in Canada with Ontario and Alberta recently announcing future implementation of such programs. 42, 47 Individuals with a first-degree family history of CRC should be specifically addressed with a consistent guideline within a population-based screening program.
